NCT06740812View on ClinicalTrials.gov

Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

May 31, 2026

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Nausea and VomitingNauseaVomiting
Interventions
DRUG

Fosaprepitant for Injection

Fosaprepitant 150mg IV administered over 15 minutes

DRUG

Metoclopramide Injection

Metoclopramide 10mg IV administered over 15 minutes

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER